Cancer Letters
Volume 290, Issue 2 , Pages 204-210, 28 April 2010

Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells

  • Ti Zhang

      Affiliations

    • Department of Hepatobiliary Surgery, Cancer Hospital of Tianjin Medical University, Huan Hu Xi Road, Tianjin 300060, PR China
  • ,
  • Hui-Chuan Sun

      Affiliations

    • Liver Cancer Institute and Zhong Shan Hospital of Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, PR China
  • ,
  • Hong-Yuan Zhou

      Affiliations

    • Department of Hepatobiliary Surgery, Cancer Hospital of Tianjin Medical University, Huan Hu Xi Road, Tianjin 300060, PR China
  • ,
  • Jing-Tao Luo

      Affiliations

    • Department of Hepatobiliary Surgery, Cancer Hospital of Tianjin Medical University, Huan Hu Xi Road, Tianjin 300060, PR China
  • ,
  • Bai-Lin Zhang

      Affiliations

    • Department of Radiotherapy, Cancer Hospital of Tianjin Medical University, Huan Hu Xi Road, Tianjin 300060, PR China
  • ,
  • Peng Wang

      Affiliations

    • Department of Neurosurgery, Cancer Hospital of Tianjin Medical University, Huan Hu Xi Road, Tianjin 300060, PR China
  • ,
  • Lu Wang

      Affiliations

    • Liver Cancer Institute and Zhong Shan Hospital of Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, PR China
  • ,
  • Lun-Xiu Qin

      Affiliations

    • Liver Cancer Institute and Zhong Shan Hospital of Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, PR China
  • ,
  • Ning Ren

      Affiliations

    • Liver Cancer Institute and Zhong Shan Hospital of Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, PR China
  • ,
  • Sheng-Long Ye

      Affiliations

    • Liver Cancer Institute and Zhong Shan Hospital of Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, PR China
  • ,
  • Qiang Li

      Affiliations

    • Department of Hepatobiliary Surgery, Cancer Hospital of Tianjin Medical University, Huan Hu Xi Road, Tianjin 300060, PR China
    • Tel./fax: +86 22 2335 9904.
  • ,
  • Zhao-You Tang

      Affiliations

    • Liver Cancer Institute and Zhong Shan Hospital of Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, PR China
    • Corresponding Author InformationCorresponding author. Tel./Fax: +86 21 6403 7181.

Received 15 February 2009; received in revised form 9 September 2009; accepted 14 September 2009. published online 12 October 2009.

Abstract 

The aim of this study was to observe the effect of interferon alpha (IFNα) on tumor endothelial cells (TECs) in highly metastatic hepatocellular carcinoma (HCC) model, and to investigate the underlying mechanism. Nude mice with HCC xenograft were treated with IFNα. Gene expression profiles of TECs were analyzed by utilizing cDNA microarray. The differentiation of tumor blood vessels was evaluated by CD31/αSMA dual immunohistochemistry. Apoptosis of TECs was determined by CD31/TUNEL double staining. The functions of TECs in adhesion and uptake of acetylated low-density lipoprotein were observed in vitro. Results showed that IFNα effectively inhibited HCC tumor growth, with decreased microvessel density, increased apoptosis in TECs and normalized tumor blood vessels. cDNA microarray analysis revealed differential gene expression patterns in TECs under the treatment of IFNα. The cell-cell contact distribution of VE-Cadherin and uptake of acetylated low-density lipoprotein were significantly inhibited by IFNα in cultivated TECs. These results suggest that IFNα may induce apoptosis and interfere with hemophilic adhesion of TECs. The changes of gene expression in TECs contribute essentially to its effect of anti-angiogenesis and the subsequent inhibition of tumor progression.

Abbreviations: HCC, hepatocellular carcinoma, IFNα, interferon alpha, TEC, tumor endothelial cell, DAPI, 4’,6-diamidino-2-phenylindole, PBS, phosphate buffered saline

Keywords: Hepatocellular carcinoma, Interferon alpha, Angiogenesis, Tumor endothelium

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3835(09)00597-7

doi:10.1016/j.canlet.2009.09.009

Cancer Letters
Volume 290, Issue 2 , Pages 204-210, 28 April 2010